BCM
ANIP icon

Bridgeway Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Bridgeway Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-23,516
Closed -$1.33M – 1477
2014
Q4 		$1.33M Sell
23,516
-50
-0.2% -$2.2K 0.03% 678
2014
Q3 		$666K Hold
23,566
– – 0.02% 944
2014
Q2 		$812K Buy
23,566
+150
+0.6% +$4.7K 0.02% 862
2014
Q1 		$734K Hold
23,416
– – 0.02% 899
2013
Q4 		$470K Hold
23,416
– – 0.01% 1064
2013
Q3 		$229K Buy
+23,416
New +$169K 0.01% 1286

Other funds holding ANIP

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Bridgeway Capital Management's ANIP Position: Q1 2015 in Review

Bridgeway Capital Management sold out of ANI Pharmaceuticals (ANIP) in Q1 2015, closing a stake of 23,516 shares — an estimated $1.33M sold.

Bridgeway Capital Management first reported a position in ANIP in Q3 2013 and held it in 6 quarters. The position peaked at $1.33M in Q4 2014. 126 funds tracked by Wall St. Rank hold ANIP as of Q1 2015.

  • Bridgeway Capital Management reported no remaining ANI Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Bridgeway Capital Management sold 23,516 ANI Pharmaceuticals shares in Q1 2015, an estimated $1.33M.
  • Bridgeway Capital Management first reported a position in ANI Pharmaceuticals in Q3 2013 and held it in 6 quarters.
  • Bridgeway Capital Management's ANI Pharmaceuticals position peaked at $1.33M in Q4 2014.
  • 126 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2015.

Based on Bridgeway Capital Management's 13F filing for Q1 2015, filed 15 May 2015.